Torrent Pharmaceuticals Ltd. has secured a credit line of .3 billion to acquire a controlling stake in JB Chemicals & Pharmaceuticals Ltd. The credit facility is supported by banks including Barclays Plc, HSBC Holdings Plc, and Standard Chartered Plc, with a maturity period of up to four years. Torrent plans to purchase 53.8% of JB Chemicals from KKR & Co. for approximately .4 billion and has made a mandatory offer for an additional 26% of shares at 1,639 rupees per share. JB Chemicals' market valuation reached .6 billion in 2024, with a 20% increase in stock price. The Indian M&A landscape has seen an 18% increase in activity in 2025, despite an 8% decline in the Asia-Pacific region. JB Chemicals focuses on pharmaceutical products for various disorders and is headquartered in Mumbai, while Torrent Pharmaceuticals is based in Ahmedabad.